Member Info for Laura2022

Does it mean more cash in 2024 or cash in early 2025 ?

5 days ago

The FDA recently finalised new guidance to help drug developers find the right dosage for cancer treatments. To navigate these new requirements, the FDA recommends the use of Model-Informed Drug Development (MIDD) – an area where Physiomics plc has extensive expertise. Our advanced modelling and simulation techniques can help you identify the optimal dosage strategies, minimising risks and maximising the potential for #regulatory and #clinical success. If you’re looking to adapt to these changes and optimise your development process, we’re here to help. Reach out to learn how our tailored solutions can guide you through this new era of oncology drug development! #FDA #DrugDevelopment #Biotech #Pharma #Oncology #OptimalDose #Dosing #Cancer #CancerDrugs #ImprovingOutcomes #MechanisticModelling #ClinicalTrials #Data

Https://www.cancer.gov/news-events/cancer-currents-blog/2024/cancer-drugs-lower-doses

Physiomics plc

1,607 followers

2w

With #ProjectOptimus gaining traction, we’re learning that lower doses can be just as effective as higher ones while reducing side effects. This shift makes computer modelling more valuable than ever in getting the dose right first time.

An excellent look at why shaking up the ‘maximum tolerated dose’ paradigm is crucial in cancer treatment. 👇

At Physiomics plc, we’re thrilled to contribute to this progress. Our expertise in quantitative and mechanistic modelling helps partners determine the optimal dose and schedule for First-in-Human trials. By aligning with the latest FDA guidelines, we strive to make treatments more personalised and effective. Reach out to learn mo

2 x buys V sell (albeit only 5 trades) and a bid price nearer 0.68 than 0.65

I suspect good news etc isn't far away

Good morning Trench

And in the june 2024 statement it went further :

Following DoseMe's acquisition by a private equity group in early 2023, Physiomics re-engaged with DoseMe's new management, culminating in the planned launch of the dosing software on the upgraded DoseMeRx platform in the second half of this year.

The companies would also identify US centres with historical patient data to further enhance the software's decision-making capabilities around GCSF usage.

Additionally, Physiomics said it was aiming to make blood sampling more convenient for patients, exploring new diagnostic devices for community or home settings, developed in partnership with Beyond Blood Diagnostics.

“I'm really pleased that we've been able to progress this initiative and the team are excited to build upon the partnership with DoseMe to further develop our personalised oncology dosing software,” said chief executive officer Dr Peter Sargent.

Take care and concentrate on the shares you ACTUALLY own

Don't disrupt

Don't lie

Don't make false accusations

Have.a good week

Just like thenold porky that used to ramp VAL, DDDD, NCYT

Good on you, you've got your mojo back

Porky9

Posted in: GDR

Posts: 7,056

Price: 3.55

No Opinion

RE: NHD Supply Chain12 Aug 2024 08:03

Yep, our biggest killer is the the big C or Heart Attacks and Strokes - GDR tech will ultimately save a heck of lot of people - all positive, just the tip of the iceberg this order.

This could be the share of the year

Porky9

Posted in: GDR

Posts: 7,056

Price: 3.175

No Opinion

RE: Screaming buy. Market cap £17 million is a bad joke.11 Aug 2024 11:02

See how it goes, now positioned for sizeable NHS contracts, TP licensing deals or could just get taken out now by a larger player - all possible.

If Share Price was back at £3 I might be more concerned but at sub 10p it’s no big concern is it and having only recently sustained the capital raising, no risk of immediate further dilution short term, they have a decent enough cash runway ahead of them to smash this.

It will be interesting to see the bull / bear fight next week but despite the dire market conditions I recon the bulls have it, far too many on the outside looking for a low entry point that could get blown away quickly on any commercial update.

Good luck

Yes...but you were only buying in the 3s

:)

I clearly said why

If you keep accusing me of being 3 different people

If you keep lying

If you keep disruption

Simple thing to do would be leave these boards and seek medical help

Fairly well?

It's gone 3.5p to 2.5p and you've gone silent

I see you dodged my GDR question yesterday so here it again

GDR now 2.6p and you've not posted since....

Certainly being hit hard at 3.42 at the moment so would expect this to move to 3.7-3.8 in fairly quick time at this rate.

See you at 10p guys, let’s see those NHS awards filtering through :)

Porky

3 things

You keep accusing me of being 3 people and as such ill keep reporting you

You've gone VERY quiet on GDR despite saying "10p soon"

I have simply taken info from a document from someone else

You need medical help

But RRR don't have any as proven by the fake photos last year

It says it in the prospectus

Have you read it ?

Buys shown as sells

Usually a sign the market makers are trying to conceal a move

I wonder on the same metrics what VAL201 could be worth

Yes Freddie

On page 11/12 Ambrose value 401 at £70mln and peak revenue of £170lln

Well found

Maidit

Only a 1/10th of the 2bln was traded yesterday so I would imagine more churn yet

On that update